Canadian FOP Network
  • Home
  • Our Role & Impact
    • About the Network
    • Volunteer Board & Officers
    • How do We Get a Cure >
      • Research
      • Clementia Pharmaceutical
      • Regeneron Pharmaceuticals
    • Financial
  • Understanding FOP
    • Diagnosis & Symptoms >
      • Prognosis
    • Life with FOP
    • Research / Clinical Trials >
      • Our Expert Partner IFOPA
  • Get Involved
    • Become a Member
    • Volunteer
    • Donate to Fund a Cure
    • Host a Fundraiser
  • Multi-Media
  • News & Events
  • Brooke Connell Golf Tournament
  • Important Contacts
  • Links to Resources
  • Our Friends Around the World
  • Blog
  • Product
  • Untitled
  • Constitution & Bylaws

Understanding FOP

FOP is a progressive and debilitating genetic disorder characterized by heterotopic ossification (HO).  The defining sign present at birth is a malformation of the great toes, which often appear to angle inward and lack a joint (in some cases, the great toes might even be missing).  In early childhood, children develop soft tissue swellings that transform into bone.  Development of such lesions is exacerbated by trauma, and surgical intervention leads to dramatic and explosive new bone growth.  The median survival of FOP patients is approximately 45 years, and death often results from complications of thoracic insufficiency syndrome. 

FOP is an extremely rare condition affecting about 1 in 1,000,000 people. 

CFOPN is a member of:

Picture

19-13085 Yonge St.
Richmond Hill, ON
L4E 0K2
Ph #: ​604-837-8460
 email: [email protected]
Registered Charity #834338691RR0001
Proudly powered by Weebly